THOMAS S. MCHUGH - 16 Jan 2024 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Chief Financial Officer
Signature
/s/ Jerad G. Seurer, Attorney-in-Fact
Issuer symbol
AVDL
Transactions as of
16 Jan 2024
Net transactions value
+$29,000
Form type
4
Filing time
16 Jan 2024, 16:36:33 UTC
Previous filing
14 Aug 2023
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVDL ADSs Purchase $29,000 +2,000 +2.5% $14.50 80,500 16 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the Issuer; ADSs may be represented by American Depositary Receipts.